Le Lézard
Classified in: Health, Science and technology
Subject: PLW

Inari to Bring Growers Proprietary GM Traits in Tandem with Novel Gene Edits


CAMBRIDGE, Mass. , Feb. 9, 2022 /PRNewswire/ -- Globally, growers are impacted by the dual challenges of growing more food while making the best use of limited resources. New solutions are required if the needs of the people and the planet are to be met. Inari, the SEEDesigntm company, aims to address these challenges using multiplex gene editing with goals of increasing yield by 20% in soybeans and 10% in corn while developing future products that require 40% less water and nitrogen. Now, by using its proprietary gene editing technology, Inari has created a unique opportunity to deliver proven GM traits in combination with novel gene edits to plants' natural DNA ? unlocking the full potential of seeds for growers and the environment.

Since the beginning of the year, Inari has been granted two U.S. patents related to gene editing GM traits:

The grant of these patents confirms the uniqueness of the approach and makes it proprietary to Inari. Additionally, Inari has 10 trait-specific patents pending, as well as five concept patent families pending which cover in general the editing of any GM trait in corn, soybeans, canola and cotton. The edits have been established using Inari's proprietary CRISPR-CasS system, and these gene edited GM traits are outside of third-party patents, enabling the path to commercialization.

"We are proud to be the first company granted patents for gene editing GM traits," said Inari CEO Ponsi Trivisvavet. "Inari can give growers access to the leading GM traits for pest control they have come to rely on, coupled with the sustainability benefits of our unique gene edits ? all available through our proprietary technology platform. We aim to commercialize our products in the coming years, providing significant value to our customers and shareholders while delivering on our environmental commitments."

The suite of GM traits to be delivered through gene editing will have the same functionality as those currently on the market, which have been proven effective by growers. Today, more than 90% of corn and soybean crops grown in the U.S. include GM traits. Globally, the commercial seed market is currently valued at $60 billion with more than half derived from GM-traited seeds. Seventeen million farmers across 29 countries deploy GM seeds on nearly 200 million hectares of farmland.

"Inari is focused on using our cutting-edge technology platform to develop novel, value-added seeds for growers," says Trivisvavet. "GM traits have become a foundational tool for growers over the past 25 years. We are pleased to apply our proprietary technology to bring these solutions to market in a new way. Our gene editing technology aims to reduce land, water and fertilizer ? by packaging this technology with our edited GM traits, we can reach more growers and increase our potential for a positive impact on the planet."

And Inari continues to expand its SEEDesigntm platform. Utilizing a two-step approach to technology, Inari uses predictive design to build blueprints for its advanced multiplex gene editing toolbox. From standard on/off editing to more unique regulations of gene expression and proprietary replacement editing, combining tools for multiple changes within a single plant allows Inari to reveal the full potential of every seed.

About Inari
Inari is embracing diversity to build a new, more sustainable food system using unsurpassed technology to unlock the full potential of seed. Through its SEEDesigntm  platform, Inari unlocks new possibilities to bring step-change products to market. Founded by Flagship Pioneering in 2016, Inari is based in Cambridge, Mass., with additional sites in West Lafayette, Ind., and Ghent, Belgium. Inari is a growing team of approximately 200 employees, leveraging AI and multiplex gene editing technology to meet the food system needs of the future. To learn more, visit Inari.com.

SOURCE Inari


These press releases may also interest you

at 06:35
Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2024. "Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our...

at 06:35
Sage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the first quarter ended March 31, 2024. "The launch of ZURZUVAE is off to...

at 06:30
Sage Veterinary Imaging (SVI) has welcomed Peter Selover to its team as president and chief operating officer. Selover had previously served as chief executive officer of Exubrion Therapeutics....

at 06:14
The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, to expand the global impact and speed up the market penetration of PolyU's...

at 06:09
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Personalized Nutrition Market ? (By Purchase Model (Subscription, One Time Purchase), By End-users (Direct Consumers, Wellness & Fitness Centers,...

at 06:05
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide. This year's...



News published on and distributed by: